Lan Coffman lab

improving lives of women with ovarian cancer through research @upmchillmancc
a focus on the stromal tumor microenvironment

[Lan Coffman lab @CoffmanLab]

@ronny_drapkin @cancerassassin1 @SantagataLab @PaolaVermeer Excited to present our work at #OCMF , such a great group of ovarian cancer researchers!

[Lan Coffman lab @CoffmanLab]

Check out our newest publication showing endometriosis-derived stroma drive ovarian clear cell cancer through iron regulation!
https://t.co/Buz5p81peP

[Lan Coffman lab @CoffmanLab]

@kcooney1234 @UPMCHillmanCC @BuckanovichLab Thank you to @kcooney1234 for the fantastic keynote at our Hillman Scientific retreat!

[Lan Coffman lab @CoffmanLab]

@JCI_insight @UPMCHillmanCC Very excited to share the promising results of our phase 1 study with ribociclib in ovarian cancer!

[JCI insight @JCI_insight]

#ClinicalMedicine: Safety demonstrated for CDK4/6 inhibitor with chemotherapy in ovarian cancer: https://t.co/3RVOnKLrzu
@CoffmanLab @UPMCHillmanCC
#Oncology

[Lan Coffman lab @CoffmanLab]

@ASCO @AnaOaknin @radcww @pammiepeters @AngelesSecord Honored to work with such an amazing group of authors on this article!

[Lan Coffman lab @CoffmanLab]

@NadineHempel @airdlab @RobinSCohen Me too! happy move :) hope it goes smoothly

[Lan Coffman lab @CoffmanLab]

@DrRaniChudasama @BrownUCancer @ASCO My pleasure! Thank you to @drdonsdizon for the invitation and the chance to meet the great group at Brown

[Lan Coffman lab @CoffmanLab]

@sarahe316422 @SGO_org Congratulations to Dr. Orellana on her important work on ovarian cancer initiation! So happy to have her in the lab

[Joshua Levenson, MD @jelevenson]

👌🙌🏼👏

[Lan Coffman lab @CoffmanLab]

We are hiring! Explore our Translational Ovarian Cancer Post-doctoral Fellow position: https://t.co/87UVAQSmLT

[Lan Coffman lab @CoffmanLab]

@TinasWish @MageeWomens @HopkinsMedicine So excited to talk aboutbour work. Such an honor to be part of this group!

[Lan Coffman lab @CoffmanLab]

@BuckanovichLab Very excited to be a part of this work and looking forward to opening the trial!

[Buckanovich Lab @BuckanovichLab]

Super excited about a new study we published today. This work shows CA-MSC are driving tumor immune exclusion and resistance to immune therapy. This study supports a new clinical trial we will launch in the spring!
https://t.co/xYCXDxdZWW

[Lan Coffman lab @CoffmanLab]

this reprogramming is reversible and associated with patient survival and may be a new therapeutic target in ovarian cancer

[Lan Coffman lab @CoffmanLab]

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis: Cell Reports https://t.co/qjU2DF7uct

[Lan Coffman lab @CoffmanLab]

we found ovarian cancer induces a mesenchymal to epithelial transition in stromal cells allowing stromal cells to bind and co-metastasize with cancer cells

[Lan Coffman lab @CoffmanLab]

@airdlab @CDMRP @mzspectrum @DelgoffeLab @UPMCHillmanCC Congrats! we just found out our application was recommended for funding too, fantastic way to start the holidays